511 related articles for article (PubMed ID: 32040577)
21. Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue.
Nakagawa N; Tanaka K; Sonohara F; Kandimalla R; Sunagawa Y; Inokawa Y; Takami H; Hayashi M; Yamada S; Kanda M; Tanaka C; Nakayama G; Koike M; Kodera Y
Anticancer Res; 2020 Dec; 40(12):6665-6676. PubMed ID: 33288560
[TBL] [Abstract][Full Text] [Related]
22. ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B.
Gong H; Liu L; Cui L; Ma H; Shen L
Mol Carcinog; 2021 Sep; 60(9):644-657. PubMed ID: 34169564
[TBL] [Abstract][Full Text] [Related]
23. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
[TBL] [Abstract][Full Text] [Related]
24. Novel evidence for m
Shimura T; Kandimalla R; Okugawa Y; Ohi M; Toiyama Y; He C; Goel A
Br J Cancer; 2022 Feb; 126(2):228-237. PubMed ID: 34675398
[TBL] [Abstract][Full Text] [Related]
25. FTO-Dependent N
Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
[TBL] [Abstract][Full Text] [Related]
26. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
[TBL] [Abstract][Full Text] [Related]
27. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.
Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H
Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767
[TBL] [Abstract][Full Text] [Related]
28. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
[TBL] [Abstract][Full Text] [Related]
29. m6A Regulators in Human Adipose Tissue - Depot-Specificity and Correlation With Obesity.
Rønningen T; Dahl MB; Valderhaug TG; Cayir A; Keller M; Tönjes A; Blüher M; Böttcher Y
Front Endocrinol (Lausanne); 2021; 12():778875. PubMed ID: 34950106
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of substrate recognition and N6-methyladenosine demethylation revealed by crystal structures of ALKBH5-RNA complexes.
Kaur S; Tam NY; McDonough MA; Schofield CJ; Aik WS
Nucleic Acids Res; 2022 Apr; 50(7):4148-4160. PubMed ID: 35333330
[TBL] [Abstract][Full Text] [Related]
31. Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases.
You Y; Fu Y; Huang M; Shen D; Zhao B; Liu H; Zheng Y; Huang L
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628623
[TBL] [Abstract][Full Text] [Related]
32. RNA N6-methyladenosine demethylase FTO targets MOXD1 promoting the malignant phenotype of gastric cancer.
Lai Y; Dong H; Xu P; Wang J; Feng W; Zhao Z; Sha L
BMC Gastroenterol; 2024 Jan; 24(1):29. PubMed ID: 38200441
[TBL] [Abstract][Full Text] [Related]
33. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L
Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897
[TBL] [Abstract][Full Text] [Related]
34. KIAA1429 regulates cell proliferation by targeting c-Jun messenger RNA directly in gastric cancer.
Miao R; Dai CC; Mei L; Xu J; Sun SW; Xing YL; Wu LS; Wang MH; Wei JF
J Cell Physiol; 2020 Oct; 235(10):7420-7432. PubMed ID: 32052427
[TBL] [Abstract][Full Text] [Related]
35. ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.
Yang Z; Cai Z; Yang C; Luo Z; Bao X
EBioMedicine; 2022 Jun; 80():104019. PubMed ID: 35490460
[TBL] [Abstract][Full Text] [Related]
36. RNA m6A modification, signals for degradation or stabilisation?
Wei G
Biochem Soc Trans; 2024 Apr; 52(2):707-717. PubMed ID: 38629637
[TBL] [Abstract][Full Text] [Related]
37. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
[TBL] [Abstract][Full Text] [Related]
38. Increased levels of N6-methyladenosine in peripheral blood RNA: a perspective diagnostic biomarker and therapeutic target for non-small cell lung cancer.
Yin H; Hong H; Yin P; Lu W; Niu S; Chen X; Xia Y; Jiang P; Huang Z
Clin Chem Lab Med; 2023 Feb; 61(3):473-484. PubMed ID: 36542027
[TBL] [Abstract][Full Text] [Related]
39. Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.
Zhang D; Ning J; Okon I; Zheng X; Satyanarayana G; Song P; Xu S; Zou MH
Cell Death Dis; 2021 May; 12(6):518. PubMed ID: 34016959
[TBL] [Abstract][Full Text] [Related]
40. FTO-Dependent
Huang H; Wang Y; Kandpal M; Zhao G; Cardenas H; Ji Y; Chaparala A; Tanner EJ; Chen J; Davuluri RV; Matei D
Cancer Res; 2020 Aug; 80(16):3200-3214. PubMed ID: 32606006
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]